current (ICa) is one of the important determinants of cardiac excitation-contraction coupling, the effect of ET-1 on the I Ca is not always clear. The controversial results appear to be due to different patchclamp methods. The present study measured the effect of ET-1 on the I Ca of rat ventricular myocytes using the perforated patch-clamp technique. The holding potential was set to Ϫ40 mV, and depolarization was applied every 10 s. ET-1 (10 nM) increased the I Ca in a monophasic manner. The current reached a steady state 15 min after the application of ET-1, when the measurement was done. Endothelin receptor subtype expression was also investigated using Western immunoblotting. ET A-receptor protein was expressed, but ETB-receptor protein was not expressed, in the cell membranes of rat ventricular myocytes. The effect of ET-1 on the I Ca was inhibited by a selective ET A-receptor antagonist, BQ-123, but not by a selective ETB-receptor antagonist, BQ-788. The effect was inhibited by protein kinase C (PKC) inhibitor chelerythrine and Ca 2ϩ /calmodulin-dependent protein kinase II (CaMKII) inhibitor KN-93, but not by its inactive analog KN-92. The effect of ET-1 was also blocked by another CaMKII inhibitor, autocamtide-2-related inhibitory peptide. These results suggest that ET-1 increases the I Ca via the ETA-receptor-PKC-CaMKII pathway. perforated patch clamp; endothelin A receptor; KN-93; BQ-123 ENDOTHELIN-1 (ET-1) IS KNOWN as a strong vasoconstrictive peptide. Production of ET-1 is increased under pathophysiological conditions in the cardiovascular system, such as heart failure (30), acute myocardial infarction (21), and hypertension (26). This peptide also directly affects cardiac muscle and shows a positive inotropic effect. However, the intracellular mechanism of the inotropic effect remains unclear. ET-1 induces phosphoinositide hydrolysis and activates protein kinase C (PKC) (11,12,28). Therefore, ET-1 increases intracellular pH by PKCinduced activation of the Na/H exchanger. Intracellular alkalization would increase contractility, because Ca 2ϩ sensitivity of the contractile elements is increased in a pH-dependent manner (17). However, there is a discrepancy between the change in intracellular pH and that in contractility when ET-1 is applied (13, 14). ET-1 increases the L-type Ca 2ϩ current (I Ca ), which is also one of the key determinants of cardiac muscle contraction, although the effect of ET-1 on I Ca is controversial (5,12,29,31,32,36). There are two distinct endothelin receptor subtypes: ET A and ET B . Stimulation of the ET A receptor induces vasoconstriction in smooth muscle cells, while that of ET B receptor induces vasorelaxation through the nitric oxide production in endothelial cells. The ET A receptor is thought to be dominant in cardiac muscle. The ET A receptor is one of the G proteincoupled receptors, and it couples with G q , which is the same as AT 1 receptor and ␣ 1A -adrenoceptor. ␣ 1A -Adrenoceptor stimulation increases the I Ca via the activation of PKC and Ca 2ϩ / calmodulin-depen...